Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor

International Journal of Cancer

Volumn 127, Issue 1, 2010, Pages 43-54

  Onori, Paolo ^a   Wise, Candace ^b   Gaudio, Eugenio ^c   Franchitto, Antonio ^c   Francis, Heather ^b   Carpino, Guido ^b   Lee, Vien ^d   Lam, Ian ^d   Miller, Timothy ^b   Dostal, David E ^b   Glaser, Shannon S ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cholangiocarcinoma; Secretin; Secretin receptor; Xenograft

Indexed keywords

CASPASE 3; CELL NUCLEUS ANTIGEN; CYCLIC AMP; HORMONE RECEPTOR; PERTUSSIS TOXIN; SECRETIN; SECRETIN RECEPTOR; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CANCER SIZE; CANCER THERAPY; CELL LEVEL; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAMPLE; TUMOR BIOPSY; BILE DUCT TUMOR; CELL DIVISION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BILE DUCT NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CYCLIC AMP; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; POLYMERASE CHAIN REACTION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; SECRETIN; SIGNAL TRANSDUCTION;

EID: 77953395337     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25028     Document Type: Article

References (43)

1. Glaser S, Francis H, Demorrow S, Lesage G, Fava G, Marzioni M, Venter J, Alpini G. Heterogeneity of the intrahepatic biliary epithelium. World J Gastroenterol 2006;12: 3523-36.
2. Fava G, Marzioni M, Benedetti A, Glaser S, DeMorrow S, Francis H, Alpini G. Molecular pathology of biliary tract cancers. Cancer Lett 2007;250:155-67.
3. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128:1655-67.
4. Malhi H, Gores GJ. Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol 2006;45: 856-67.
5. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002;2:10.
6. Lam IP, Siu FK, Chu JY, Chow BK. Multiple actions of secretin in the human body. Int Rev Cytol 2008;265:159-90.
7. Ulrich CD, II, Holtmann M, Miller LJ. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology 1998;114:382-97.
8. Farouk M, Vigna SR, Haebig JE, Gettys TW, McVey DC, Chari R, Pruthi RS, Meyers WC. Secretin receptors in a new preparation of plasma membranes from intrahepatic biliary epithelium. J Surg Res 1993;54:1-6. (Pubitemid 23060193)
9. Alpini G, Ulrich CD, II, Phillips JO, Pham LD, Miller LJ, LaRusso NF. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 1994;266:G922-8.
10. Korner M, Hayes GM, Rehmann R, Zimmermann A, Scholz A, Wiedenmann B, Miller LJ, Reubi JC. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. J Hepatol 2006;45:825-35.
11. - exchange in cholangiocytes. Am J Physiol 1997;273: G303-13.
12. - channels in bile duct epithelial cells through a cAMP-dependent mechanism. Am J Physiol 1994; 266:G731-6.
13. Martinez-Anso E, Castillo JE, Diez J, Medina JF, Prieto J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology 1994;19:1400-6.
14. Alpini G, Lenzi R, Sarkozi L, Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 1988;81:569-78.
15. Alvaro D, Cho WK, Mennone A, Boyer JL. Effect of secretion on intracellular pH regulation in isolated rat bile duct epithelial cells. J Clin Invest 1993;92: 1314-25.
16. Alpini G, Glaser SS, Ueno Y, Pham L, Podila PV, Caligiuri A, LeSage G, LaRusso NF. Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol 1998;274: G767-75.
17. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter-Suermann D, Prellwitz W, Meyer zum Buschenfelde KH. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol 1985;1:579-96.
18. Kusaka Y, Muraoka A, Tokiwa T, Sato J. [Establishment and characterization of a human cholangiocellular carcinoma cell line]. Hum Cell 1988;1:92-4.
19. Saijyo S, Kudo T, Suzuki M, Katayose Y, Shinoda M, Muto T, Fukuhara K, Suzuki T, Matsuno S. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1. Tohoku J Exp Med 1995;177:61-71.
20. 2+-dependent protein kinase C-α. J Hepatol 2001;34:284-91.
21. Grubman SA, Perrone RD, Lee DW, Murray SL, Rogers LC, Wolkoff LI, Mulberg AE, Cherington V, Jefferson DM. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol 1994;266: G1060-70.
22. Han C, Leng J, Demetris AJ, Wu T. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest. Cancer Res 2004;64:1369-76.
23. Wu T, Han C, Lunz JG, III, Michalopoulos G, Shelhamer JH, Demetris AJ. Involvement of 85-kDa cytosolic phospholipase A2 and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. Hepatology 2002; 36:363-73.
24. Han C, Wu T. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 2005;280: 24053-63.
25. Alpini G, Invernizzi P, Gaudio E, Venter J, Kopriva S, Bernuzzi F, Onori P, Franchitto A, Coufal M, Frampton G, Alvaro D, Lee SP, et al. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res 2008;68:9184-93.
26. Marienfeld C, Tadlock L, Yamagiwa Y, Patel T. Inhibition of cholangiocarcinoma growth by tannic acid. Hepatology 2003;37: 1097-104.
27. Kalejta RF, Shenk T, Beavis AJ. Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry. Cytometry 1997;29: 286-91.
28. Francis H, Franchitto A, Ueno Y, Glaser S, DeMorrow S, Venter J, Gaudio E, Alvaro D, Fava G, Marzioni M, Vaculin B, Alpini G. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. Lab Invest 2007;87:473-87.
29. 2+-, and protein kinase C α-dependent mechanisms. Hepatology 2000;32:17-25.
30. 2+- dependent PKC isoforms. Liver Int 2003;23: 78-88.
31. Alpini G, Glaser S, Robertson W, Phinizy JL, Rodgers RE, Caligiuri A, LeSage G. Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. Am J Physiol 1997;273: G518-29.
32. Alpini G, Glaser SS, Ueno Y, Rodgers R, Phinizy JL, Francis H, Baiocchi L, Holcomb LA, Caligiuri A, LeSage GD. Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology 1999;116:179-86.
33. Trinquet E, Fink M, Bazin H, Grillet F, Maurin F, Bourrier E, Ansanay H, Leroy C, Michaud A, Durroux T, Maurel D, Malhaire F, et al. D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. Anal Biochem 2006;358:126-35.
34. Glaser SS, Ueno Y, DeMorrow S, Chiasson VL, Katki KA, Venter J, Francis HL, Dickerson IM, DiPette DJ, Supowit SC, Alpini GD. Knockout of α-calcitonin generelated peptide reduces cholangiocyte proliferation in bile duct ligated mice. Lab Invest 2007;87:914-26.
35. Ribeiro-Neto FA, Rodbell M. Pertussis toxin induces structural changes in G alpha proteins independently of ADP-ribosylation. Proc Natl Acad Sci USA 1989; 86:2577-81.
36. Kanno N, LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol 2001;281:G612-25.
37. Francis H, Glaser S, Ueno Y, Lesage G, Marucci L, Benedetti A, Taffetani S, Marzioni M, Alvaro D, Venter J, Reichenbach R, Fava G, et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/ Src/MEK/ERK1/2 pathway. J Hepatol 2004; 41:528-37.
38. Glaser S, Alvaro D, Francis H, Ueno Y, Marucci L, Benedetti A, De Morrow S, Marzioni M, Mancino MG, Phinizy JL, Reichenbach R, Fava G, et al. Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. Am J Physiol Gastrointest Liver Physiol 2006;290:G813-26.
39. Lam IP, Glaser SS, Gaudio E, Ueno Y, Chow BK, Antonella V, Sferra R, Onori P, Alvaro D, Vaculin B, Venter J, Francis H, et al. Knockout of secretin receptor decreases the proliferation of large cholangiocytes in bile duct ligated (BDL) mice. Hepatology 2008;48:416A.
40. Kanno N, Lesage G, Phinizy JL, Glaser S, Francis H, Alpini G. Stimulation of α2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. Hepatology 2002;35:1329-40.
41. Kiba T, Tsuda H, Pairojkul C, Inoue S, Sugimura T, Hirohashi S. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Mol Carcinog 1993;8: 312-8.
42. Stutes M, Tran S, DeMorrow S. Genetic and epigenetic changes associated with cholangiocarcinoma: from DNA methylation to microRNAs. World J Gastroenterol 2007;13:6465-9.
43. Fava G, Marucci L, Glaser S, Francis H, De Morrow S, Benedetti A, Alvaro D, Venter J, Meininger C, Patel T, Taffetani S, Marzioni M, et al. γ-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway. Cancer Res. 2005;65:11437-46.